BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24140178)

  • 1. Rational design of gold nanoparticles functionalized with carboranes for application in Boron Neutron Capture Therapy.
    Ciani L; Bortolussi S; Postuma I; Cansolino L; Ferrari C; Panza L; Altieri S; Ristori S
    Int J Pharm; 2013 Dec; 458(2):340-6. PubMed ID: 24140178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphiphilic Polycarbonates from Carborane-Installed Cyclic Carbonates as Potential Agents for Boron Neutron Capture Therapy.
    Xiong H; Wei X; Zhou D; Qi Y; Xie Z; Chen X; Jing X; Huang Y
    Bioconjug Chem; 2016 Sep; 27(9):2214-23. PubMed ID: 27548011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent Organic Polymer as a Carborane Carrier for Imaging-Facilitated Boron Neutron Capture Therapy.
    Shi Y; Fu Q; Li J; Liu H; Zhang Z; Liu T; Liu Z
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55564-55573. PubMed ID: 33327054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy.
    Worm DJ; Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Med Chem; 2020 Mar; 63(5):2358-2371. PubMed ID: 31589041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
    Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico carborane docking to proteins and potential drug targets.
    Calvaresi M; Zerbetto F
    J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy.
    Lai CH; Lin YC; Chou FI; Liang CF; Lin EW; Chuang YJ; Lin CC
    Chem Commun (Camb); 2012 Jan; 48(4):612-4. PubMed ID: 22114760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, development and characterization of multi-functionalized gold nanoparticles for biodetection and targeted boron delivery in BNCT applications.
    Mandal S; Bakeine GJ; Krol S; Ferrari C; Clerici AM; Zonta C; Cansolino L; Ballarini F; Bortolussi S; Stella S; Protti N; Bruschi P; Altieri S
    Appl Radiat Isot; 2011 Dec; 69(12):1692-7. PubMed ID: 21641810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy.
    Lai CH; Lai NC; Chuang YJ; Chou FI; Yang CM; Lin CC
    Nanoscale; 2013 Oct; 5(19):9412-8. PubMed ID: 23958787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
    J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
    Takeuchi I; Nomura K; Makino K
    Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery.
    Yinghuai Z; Peng AT; Carpenter K; Maguire JA; Hosmane NS; Takagaki M
    J Am Chem Soc; 2005 Jul; 127(27):9875-80. PubMed ID: 15998093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
    Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-Loaded Carborane-Conjugated Polymeric Nanoparticles as Delivery System for Combination Cancer Therapy.
    Xiong H; Zhou D; Qi Y; Zhang Z; Xie Z; Chen X; Jing X; Meng F; Huang Y
    Biomacromolecules; 2015 Dec; 16(12):3980-8. PubMed ID: 26564472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a carborane-containing cholesterol derivative and evaluation as a potential dual agent for MRI/BNCT applications.
    Alberti D; Toppino A; Geninatti Crich S; Meraldi C; Prandi C; Protti N; Bortolussi S; Altieri S; Aime S; Deagostino A
    Org Biomol Chem; 2014 Apr; 12(15):2457-67. PubMed ID: 24604345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In vivo Evaluation.
    Pulagam KR; Gona KB; Gómez-Vallejo V; Meijer J; Zilberfain C; Estrela-Lopis I; Baz Z; Cossío U; Llop J
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591329
    [No Abstract]   [Full Text] [Related]  

  • 18. Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas.
    Dai C; Cai F; Hwang KC; Zhou Y; Zhang Z; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wei J; Jiao Y; Wei Z; Ma W; Wang R
    Sci China Life Sci; 2013 Feb; 56(2):163-73. PubMed ID: 23334699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A carborane-derivative "click" reaction under heterogeneous conditions for the synthesis of a promising lipophilic MRI/GdBNCT agent.
    Toppino A; Bova ME; Geninatti Crich S; Alberti D; Diana E; Barge A; Aime S; Venturello P; Deagostino A
    Chemistry; 2013 Jan; 19(2):721-8. PubMed ID: 23154917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of using boric acid as a boron drug for boron neutron capture therapy for osteosarcoma.
    Hsu CF; Lin SY; Peir JJ; Liao JW; Lin YC; Chou FI
    Appl Radiat Isot; 2011 Dec; 69(12):1782-5. PubMed ID: 21420871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.